CONMED Sees Q3 Revenue $315M - $ 318M Vs $318.66M Est.; Adj. EPS Growth Exceeding Prior Of 9% - 11 %
Portfolio Pulse from Benzinga Newsdesk
CONMED Corporation has announced its Q3 revenue forecast to be between $315 million and $318 million, slightly below the estimated $318.66 million. However, the company expects its adjusted EPS growth to exceed the previous guidance of 9% to 11%.
October 04, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
CONMED's Q3 revenue forecast is slightly below estimates, but the company expects adjusted EPS growth to exceed previous guidance. This mixed outlook may lead to varied investor reactions.
The revenue forecast being slightly below estimates could be seen negatively, but the positive outlook on EPS growth may offset this. Investors might have mixed reactions, leading to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100